-transparent.png){kind=logo}
We report a case of pulmonary fibrosis in an infant receiving amiodarone for treatment of intractable atrioventricular reentrant tachycardia secondary to Wolff-Parkinson-White syndrome. At 9 months, a screening chest radiograph showed a diffuse interstitial infiltrate in an asymptomatic, thriving infant. Amiodarone was discontinued and the pulmonary fibrosis resolved gradually over 6 months. This case documents the first report of amiodarone induced pulmonary fibrosis in the pediatric age group. We speculate that as amiodarone is used more frequently to manage pediatric arrhythmias, pulmonary fibrosis, a known complication of this antiarrhythmia in adults may be seen with increasing frequency in children.
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
January 1997,
Orvosi hetilap,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
August 1996,
Orvosi hetilap,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
January 1985,
Revista medica de Chile,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
January 1984,
Revista espanola de cardiologia,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
October 2000,
Intensive care medicine,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
January 1984,
Experimental lung research,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
October 2015,
The journal of pathology. Clinical research,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
June 1996,
Toxicology,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
January 2006,
Revista portuguesa de pneumologia,
P N Bowers, and
J Fields, and
D Schwartz, and
L E Rosenfeld, and
R Nehgme
April 1987,
The Journal of laboratory and clinical medicine,
